You are here

Biolidics inks deal to distribute Chinese biotech's Covid-19 test kits

CATALIST-LISTED medtech firm Biolidics has entered into an agreement with Chinese biotech JOYSBIO (Tianjin) Biotechnology Co to distribute the latter's Covid-19 test kits.

JOYSBIO owns the medical device known as the "SARS-CoV-2 antigen rapid test kit (colloidal gold)", Biolidics said in...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes